mFast-SeqS-Based Aneuploidy Score in Circulating Cell-Free DNA Is a Prognostic Biomarker in Prostate Cancer

Scientists investigated the prognostic value of dichotomized aneuploidy scores as well as circulating tumor cell counts in 131 metastatic castration-resistant prostate cancer patients prior to treatment with cabazitaxel.
[Molecular Oncology]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News